- WHATS NEW?
- Low HDL-C: key predictor of metabolic syndrome in African American women
- Meta-analysis shows positive effects of nicotinic acid on CV events
- Low HDL-C: increasing problem in adolescents
- Niacin restores vasoprotective effects of HDL in type 2 diabetes
- Low HDL-C is common despite statin therapy
- Insights from VOYAGER on statin-induced HDL response
- rHDL attenuates platelet hyperreactivity in type 2 diabetics
- HATS, FATS and AFREGS Metsyn analysis highlights need to target HDL
- Analysis of ARBITER 6-HALTS: HDL Forum Editor, Professor Philip Barter
- New study shows plaque regression with nicotinic acid on top of statin therapy
For further information contact:
Mike Gibbs
Sherborne Gibbs Limited
Edgbaston House
3 Duchess Place
Birmingham
B16 8NH
UK
Tel: +44 121 454 4114
Fax: +44 121 454 1190
E-mail: mgibbs@sherbornegibbs.co.uk
Corporate sponsor
